InsidersTradesSigma
Track the 贝瑞基因 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 贝瑞基因 has logged 5 reports. Market capitalisation: €3.1bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 高扬. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
贝瑞基因 is a company specializing in the health and pharmaceutical sector, providing genomic and diagnostic services. It is listed on the XSHE market.